Moreover, our results also indicated that together, the four glycolysis-related genes, CHPF, AK3, GALK1, and NUP188, form a promising prognostic biomarker that could offer insights for the clinical research and treatment of BC. This evidence concerns the gene AK3 and breast cancer.